CONSOLIDATED CONDENSED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($)	3 Months Ended
	Mar. 31, 2026	Mar. 31, 2025
CASH FLOWS FROM OPERATING ACTIVITIES
Net Loss	$ (2,090,155)	$ (1,877,301)
Adjustments to Reconcile Net Loss to Net Cash Used in Operating Activities:
Depreciation	16,700	6,694
Amortization	9,165	10,103
Amortization of Capitalized Share-Based Payments	44,578	44,118
Share-Based Compensation under Equity Incentive Plan	79,524	142,645
Change in Fair Value of Derivative Liabilities	4,567	(5,105)
Change in Inventory Reserve	(251,677)
Changes in Operating Assets and Liabilities:
Accounts Receivable	173,808	(1,495)
Prepaid and Other Assets	(742,717)	131,689
Inventory	(2,002)	(330,474)
Accounts Payable and Accrued Liabilities	11,735	261,905
Accrued Interest, net	4,915	19,855
Net Cash Used in Operating Activities	(2,741,559)	(1,597,366)
CASH FLOWS FROM INVESTING ACTIVITIES
Capitalization of Patents		(2,804)
Purchases of Fixed Assets	(30,000)	(2,678)
Acquisition of Intangibles	(11,440)
Maturities of Short-Term Investments	1,235,000	1,708,000
Net Cash Provided by Investing Activities	1,193,560	1,702,518
CASH FLOWS FROM FINANCING ACTIVITIES
Net Proceeds from ATM Offering	3,369,752
Net Proceeds from January 2025 Offering		804,346
Net Proceeds from February 2025 Offering		908,627
Shares Withheld for Net Share Settlement of Performance Bonuses		(18,000)
Proceeds from Exercise of Pre-Funded Warrants		1,926
Net Cash Provided by Financing Activities	3,369,752	1,696,899
Effect of Exchange Rate Changes on Cash	5,942	(9,904)
Change in Cash and Cash Equivalents	1,827,695	1,792,147
Cash and Cash Equivalents—Beginning of Period	1,510,065	1,659,353
Cash and Cash Equivalents—End of Period	3,337,760	3,451,500
NONCASH INVESTING/FINANCING ACTIVITIES
Purchases of Fixed Assets included in Accounts Payable		10,000
Capitalized Patent Costs included in Accounts Payable	16,576
Gross Shares Issued for Annual Performance Bonuses		$ 121,544